A new bill introduced in the Utah Legislature seeks to create a study of certain medications that are prescribed to transgender youth in order to help them transition.
The bill, sponsored by Rep. Brad Daw (R-Orem), would create such a study, and direct it to “conduct a review of any available scientific research related to the administration of a gonadotropin releasing hormone agent to a minor for the purpose of facilitating the minor’s desire to present or appear in a manner that is inconsistent with the minor’s sex, and any side effects of that use.”
Daw, told Salt Lake City’s FOX 13 in a text message that in investigating the topic of minors who undergo a gender transition, he became concerned about the short-term and long-term side effects of puberty blockers that are used to assist in a transition.
“I believe that having the state take a closer at this is worth doing,” Daw said.
If approved, the bill would require any information about transition-related medications to be submitted by November to the Utah State Legislature’s Health and Human Services Committee.
The doctor in charge of running the study would be required to have a degree in medicine, pharmacology or a related field, according to the bill.
Opponents of the bill worry that the study may be used by opponents of transgender rights to propose more sweeping bills — similar to those introduced in other states this year — to restrict minors’ ability to access to hormones or puberty blockers by punishing prescribers.
“It’s a much better bill in terms of not trying to restrict people’s access,” Candice Metzler, the director of Transgender Education Advocates of Utah, told FOX 13 when comparing it to legislation in other states.
But Metzler said her group still does not support the bill, arguing that there is already government-funded and peer-reviewed research on the subject that is easy enough for lawmakers to access if they so wish.
She also objects to language in the bill referring to a minor’s biological sex.
“Sex is not what people identify with,” said Metzler. “I just think part of the problem is the language further complicates things and it does leave questions about what the purpose of the study is.”
A federal judge in Oregon issued a blistering ruling against the U.S. Department of Health and Human Services and Secretary Robert F. Kennedy Jr., blocking their efforts to yank federal funding from providers of gender-affirming care for minors.
At the center of the case is the so-called "Kennedy Declaration," in which the HHS secretary claimed that gender-affirming care does not meet accepted medical guidelines, lacks evidence of benefit for treating gender dysphoria, and may cause long-term harm.
At the time, critics said Kennedy based the declaration on an HHS review of gender-affirming care that was anonymously produced and rushed through in 90 days without peer review, in order to comply with President Trump's executive order limiting minors’ access to such treatments.
Judge Mustafa Kasubhai has ruled that Health and Human Services Secretary Robert F. Kennedy, Jr. overstepped his authority by trying to restrict hospitals from providing gender-affirming care to transgender minors. He found that Kennedy failed to follow required administrative procedures when issuing a declaration last December claiming such care does not meet accepted medical standards.
The so-called "Kennedy declaration" accompanied an HHS announcement proposing two rules aimed at restricting gender-affirming care for transgender minors.
Wisconsin Gov. Tony Evers vetoed five anti-LGBTQ bills passed by the state’s Republican-led legislature.
The bills would have barred transgender athletes assigned male at birth from competing on female-designated sports teams in both K-12 schools and colleges; required school boards to adopt policies forcing teachers to out transgender students to their parents and obtain permission before allowing changes to names or pronouns; prohibited minors from accessing gender-affirming care; and allowed people who experience "regret" after such care to sue providers until age 33.
These are challenging times for news organizations. And yet it’s crucial we stay active and provide vital resources and information to both our local readers and the world. So won’t you please take a moment and consider supporting Metro Weekly with a membership? For as little as $5 a month, you can help ensure Metro Weekly magazine and MetroWeekly.com remain free, viable resources as we provide the best, most diverse, culturally-resonant LGBTQ coverage in both the D.C. region and around the world. Memberships come with exclusive perks and discounts, your own personal digital delivery of each week’s magazine (and an archive), access to our Member's Lounge when it launches this fall, and exclusive members-only items like Metro Weekly Membership Mugs and Tote Bags! Check out all our membership levels here and please join us today!
You must be logged in to post a comment.